Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck restructuring Programs — Total Period Charges Across All Programs ($M) ($M)
Form 10-Q / 10-K Restructuring Footnote
Latest, FY2025
2,551
Period ended Dec 31, 2025
Change on a year earlier
+187.3%
888 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring Programs — Total Period Charges Across All Programs ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,551 | +187.3% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 888 | -4.8% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 933 | +40.1% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 666 | -23.3% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 868 | -1.4% | Form 10-K (filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 880 | -3.8% | Form 10-K (filed 2023-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 915 | +39.1% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 658 | -29.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 927 | -15.7% | Form 10-K (filed 2020-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 1,100 | – | Form 10-K (filed 2019-02-27) ↗ |
Breakdown
What makes up restructuring programs — total period charges across all programs ($m)
Cite this data
StockData. (2026). Merck Restructuring Programs — Total Period Charges Across All Programs ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr_total_all
See every metric in the Merck KPI table. Data updated Oct 26, 2026.